CEFYD-CV 750
Anti-Infective
CEFYD-CV 750
Cephalexin Extended Release & Clavulanate Potassium Tablets
CEFYD-CV 750 extended-release tablets marketed by Yadds Laboratories Pvt. Ltd.
A cephalosporin extended-release combination designed to support sustained antibacterial action across the dosing interval, for use under medical guidance.
- Cephalexin ER 750 mg + Clavulanate 125 mg
- Extended-release profile
- First-generation cephalosporin combination
| Brand Name | CEFYD-CV 750 |
|---|---|
| Composition | Each film-coated tablet contains Cephalexin (Extended Release) 750 mg + Clavulanate Potassium 125 mg. |
| Dosage Form | Extended-Release Tablets |
| Strength | 750 mg + 125 mg |
| Therapeutic Category | Anti-Infective |
| Pack Size | 10 x 10 Tablets |
| Dosage | As directed by the physician. |
| Storage | Store below 30°C. Protect from light & moisture. Keep out of reach of children. |
Marketed By
Yadds Laboratories Pvt. Ltd.
Product Enquiry
Enquire about CEFYD-CV 750
Interested in this product? Send us your details and our team will respond with the information you need.
